Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use

被引:44
作者
Aquib, Md [1 ]
Farooq, Muhammad A. [1 ]
Banerjee, Parikshit [1 ]
Akhtar, Fahad [2 ]
Filli, Mensura S. [1 ]
Boakye-Yiadom, Kofi O. [1 ]
Kesse, Samuel [1 ]
Raza, Faisal [1 ]
Maviah, Mily B. J. [1 ]
Mavlyanova, Rukhshona [1 ]
Wang, Bo [1 ]
机构
[1] China Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China
关键词
biocompatibility; chemotherapeutics; cytotoxicity; functionalization; mesoporous silica nanoparticles; IN-VIVO; CONTROLLED-RELEASE; MULTIFUNCTIONAL NANOPARTICLES; CANCER-CELLS; LOGIC GATE; PARTICLES; NANOCARRIERS; SYSTEM; BIODISTRIBUTION; NANOMEDICINE;
D O I
10.1002/jbm.a.36770
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
For cancer therapy, the usefulness of mesoporous silica nanoparticles (MPSNPs) has been widely discussed, likely due to its inorganic nature and excellent structural features. The MPSNPs-based chemotherapeutics have been promisingly delivered to their target sites that help to minimize side effects and improve therapeutic effectiveness. A wide array of studies have been conducted to functionalize drug-loaded MPSNPs using targeting ligands and stimuli-sensitive substances. In addition, anticancer drugs have been precisely delivered to their target sites using MPSNPs, which respond to multi-stimuli. Furthermore, MPSNPs have been extensively tested for their safety and compatibility. The toxicity level of MPSNPs is substantially lower as compared to that of colloidal silica; however, in oxidative stress, they exhibit cytotoxic features. The biocompatibility of MPSNPs can be improved by modifying their surfaces. This article describes the production procedures, functionalization, and applications of biocompatible MPSNPs in drug delivery.
引用
收藏
页码:2643 / 2666
页数:24
相关论文
共 169 条
[1]   Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments [J].
Alvarez-Berrios, Merlis P. ;
Sosa-Cintron, Naisha ;
Rodriguez-Lugo, Mariel ;
Juneja, Ridhima ;
Vivero-Escoto, Juan L. .
JOURNAL OF CHEMISTRY, 2016, 2016
[2]   Snap-Top Nanocarriers [J].
Ambrogio, Michael W. ;
Pecorelli, Travis A. ;
Patel, Kaushik ;
Khashab, Niveen M. ;
Trabolsi, All ;
Khatib, Hussam A. ;
Botros, Youssry Y. ;
Zink, Jeffrey I. ;
Stoddarrt, J. Fraser .
ORGANIC LETTERS, 2010, 12 (15) :3304-3307
[3]   In Vivo Computed Tomography/Photoacoustic Imaging and NIR-Triggered Chemo-Photothermal Combined Therapy Based on a Gold Nanostar-, Mesoporous Silica-, and Thermosensitive Liposome-Composited Nanoprobe [J].
An, Jie ;
Yang, Xiao-Quan ;
Cheng, Kai ;
Song, Xian-Lin ;
Zhang, Lin ;
Li, Cheng ;
Zhang, Xiao-Shuai ;
Xuan, Yang ;
Song, Yuan-Yang ;
Fang, Bi-Yun ;
Hou, Xiao-Lin ;
Zhao, Yuan-Di ;
Liu, Bo .
ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (48) :41748-41759
[4]   pH Responsive Release of Doxorubicin to the Cancer Cells by Functionalized Multi-Walled Carbon Nanotubes [J].
Anbarasan, B. ;
Babu, S. Vignesh ;
Elango, K. ;
Shriya, B. ;
Ramaprabhu, S. .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (07) :4799-4805
[5]   THE OPTICS OF HUMAN-SKIN [J].
ANDERSON, RR ;
PARRISH, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 77 (01) :13-19
[6]  
Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
[7]   Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery [J].
Baeza, Alejandro ;
Colilla, Montserrat ;
Vallet-Regi, Maria .
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (02) :319-337
[8]   Magnetically Triggered Multidrug Release by Hybrid Mesoporous Silica Nanoparticles [J].
Baeza, Alejandro ;
Guisasola, Eduardo ;
Ruiz-Hernandez, Eduardo ;
Vallet-Regi, Maria .
CHEMISTRY OF MATERIALS, 2012, 24 (03) :517-524
[9]   Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding [J].
Bagwe, RP ;
Hilliard, LR ;
Tan, WH .
LANGMUIR, 2006, 22 (09) :4357-4362
[10]   Silica particles:: A novel drug-delivery system [J].
Barbé, C ;
Bartlett, J ;
Kong, LG ;
Finnie, K ;
Lin, HQ ;
Larkin, M ;
Calleja, S ;
Bush, A ;
Calleja, G .
ADVANCED MATERIALS, 2004, 16 (21) :1959-1966